• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1011708-38
Device Problems Peeled/Delaminated (1454); Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/21/2015
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Evaluation summary: the device was returned for analysis with multiple areas with shredding strands present on the distal shaft of the sds between the proximal seal and the mid-lap seal.However, the failure to advance could not be replicated in a testing environment as it was based on operational circumstances.Based on the visual and dimensional analysis of the returned stent implant, there is no indication of a product quality issue with respect to manufacture, design or labeling.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history of the reported lot did not indicate a lot specific quality issue.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.(b)(4).
 
Event Description
It was reported that the procedure was to treat a mildly tortuous, mildly calcified and 90% stenosed mid left anterior descending artery.Pre-dilatation was performed with a 2.5 x 15 mm trek balloon catheter.A 2.75 x 38 mm xience prime stent delivery system could not cross the lesion due to the anatomy.Another 2.75 x 38 mm xience prime stent was successfully deployed to complete the procedure.There was no clinically significant delay in procedure and no adverse patient effects.No additional information was provided.Returned device analysis revealed there was peeling on the distal shaft.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key5177814
MDR Text Key29816513
Report Number2024168-2015-06348
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 10/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/14/2017
Device Catalogue Number1011708-38
Device Lot Number4110641
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/28/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/07/2015
Initial Date FDA Received10/26/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-